The primary objective of the study is to determine the maximally tolerated photodynamic
therapy (PDT) dose and drug-light interval of PDT using light and HPPH in patients with
pleural malignancy who have undergone a maximal resection.
Phase:
Phase 1
Details
Lead Sponsor:
Abramson Cancer Center of the University of Pennsylvania